|
Year of Diagnosis |
Total | In Situ | Localized | Regional | Distant | Unknown | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
| 2016-2020 | 187 | 36 | 19.3 | 98 | 52.4 | 39 | 20.9 | 10 | 5.3 | 4 | 2.1 |
| 2015-2019 | 197 | 38 | 19.3 | 100 | 50.8 | 39 | 19.8 | 13 | 6.6 | 7 | 3.6 |
| 2014-2018 | 213 | 44 | 20.7 | 104 | 48.8 | 44 | 20.7 | 12 | 5.6 | 9 | 4.2 |
| 2013-2017 | 214 | 45 | 21.0 | 107 | 50.0 | 41 | 19.2 | 11 | 5.1 | 10 | 4.7 |
| 2012-2016 | 207 | 35 | 16.9 | 106 | 51.2 | 46 | 22.2 | 10 | 4.8 | 10 | 4.8 |
| 2011-2015 | 203 | 39 | 19.2 | 91 | 44.8 | 51 | 25.1 | 9 | 4.4 | 13 | 6.4 |
| 2010-2014 | 206 | 41 | 19.9 | 95 | 46.1 | 50 | 24.3 | 7 | 3.4 | 13 | 6.3 |
| 2009-2013 | 200 | 38 | 19.0 | 98 | 49.0 | 45 | 22.5 | 9 | 4.5 | 10 | 5.0 |
| 2008-2012 | 205 | 37 | 18.0 | 106 | 51.7 | 44 | 21.5 | 9 | 4.4 | 9 | 4.4 |
| 2007-2011 | 217 | 45 | 20.7 | 108 | 49.8 | 45 | 20.7 | 11 | 5.1 | 8 | 3.7 |
| 2006-2010 | 205 | 36 | 17.6 | 109 | 53.2 | 42 | 20.5 | 9 | 4.4 | 9 | 4.4 |
| 2005-2009 | 190 | 33 | 17.4 | 101 | 53.2 | 41 | 21.6 | 7 | 3.7 | 8 | 4.2 |
| 2004-2008 | 170 | 30 | 17.6 | 83 | 48.8 | 42 | 24.7 | 7 | 4.1 | 8 | 4.7 |
| 2003-2007 | 181 | 29 | 16.0 | 86 | 47.5 | 43 | 23.8 | 10 | 5.5 | 13 | 7.2 |
| 2002-2006 | 183 | 27 | 14.8 | 92 | 50.3 | 43 | 23.5 | 8 | 4.4 | 13 | 7.1 |
| 2001-2005 | 190 | 28 | 14.7 | 96 | 50.5 | 46 | 24.2 | 11 | 5.8 | 9 | 4.7 |
| 2000-2004 | 197 | 28 | 14.2 | 100 | 50.8 | 49 | 24.9 | 13 | 6.6 | 7 | 3.6 |
| 1999-2003 | 209 | 28 | 13.4 | 112 | 53.6 | 50 | 23.9 | 11 | 5.3 | 8 | 3.8 |
| 1998-2002 | 186 | 27 | 14.5 | 99 | 53.2 | 49 | 26.3 | 7 | 3.8 | 4 | 2.2 |
| 1997-2001 | 172 | 28 | 16.3 | 89 | 51.7 | 43 | 25.0 | 7 | 4.1 | 5 | 2.9 |
| 1996-2000 | 167 | 28 | 16.8 | 88 | 52.7 | 40 | 24.0 | 3 | 1.8 | 8 | 4.8 |
| 1995-1999 | 146 | 25 | 17.1 | 77 | 52.7 | 31 | 21.2 | 3 | 2.1 | 10 | 6.8 |
| 1994-1998 | 133 | 20 | 15.0 | 68 | 51.1 | 26 | 19.5 | 7 | 5.3 | 12 | 9.0 |
| 1993-1997 | 142 | 24 | 16.9 | 75 | 52.8 | 24 | 16.9 | 7 | 4.9 | 12 | 8.5 |
| 1992-1996 | 157 | 21 | 13.4 | 87 | 55.4 | 27 | 17.2 | 6 | 3.8 | 16 | 10.2 |
| 1991-1995 | 158 | 23 | 14.6 | 81 | 51.3 | 31 | 19.6 | 7 | 4.4 | 16 | 10.1 |
| 1990-1994 | 177 | 25 | 14.1 | 85 | 48.0 | 41 | 23.2 | 7 | 4.0 | 19 | 10.7 |
| 1989-1993 | 190 | 29 | 15.3 | 94 | 49.5 | 43 | 22.6 | 3 | 1.6 | 21 | 11.1 |
| 1988-1992 | 182 | 26 | 14.3 | 89 | 48.9 | 40 | 22.0 | 4 | 2.2 | 23 | 12.6 |
| 1987-1991 | 167 | 25 | 15.0 | 76 | 45.5 | 38 | 22.8 | 6 | 3.6 | 22 | 13.2 |
| 1986-1990 | 151 | 20 | 13.2 | 70 | 46.4 | 32 | 21.2 | 8 | 5.3 | 21 | 13.9 |
| 1985-1989 | 141 | 15 | 10.6 | 70 | 49.6 | 30 | 21.3 | 7 | 5.0 | 19 | 13.5 |
| Notes: |
|---|
|
In Situ Stage represents the presence of malignant cells within the cell group from which they arose, with no penetration of basement membrane of the tissue and no stromal invasion. |
| Localized Stage represents invasive cancer confined to the organ of origin or intralumenal extension where specified as an intralumenal extension to immediately contiguous segments of the large bowel. |
| Regional Stage represents direct extension to adjacent organs or tissues or involvement of the regional lymph nodes. |
| Distant Stage represents direct continuity to non-adjacent organs, discontinuous metastasis or involvement of the distant lymph nodes. |
| COVID-19 Pandemic: In 2020, the highly publicized impact of the COVID-19 pandemic on health services and the consequential delays and reductions in cancer screening and diagnosis led to a decline in the 2020 incidence rates for most cancer sites. Because 2020 was a temporary, anomalous year, it can bias estimates such as cancer incidence trends. |
| Source : Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2022. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services. |
|
Last Updated : April 13, 2023 |